Results 121 to 130 of about 26,737 (201)

Therapeutic drug monitoring of first-line anti-tuberculosis drugs: impact of dose modification on plasma drug concentrations in pulmonary and extrapulmonary tuberculosis. [PDF]

J Clin Tuberc Other Mycobact Dis
Alavandar A.
europepmc   +1 more source

Saliva as an Alternative Matrix for Pharmacokinetic Research and Therapeutic Drug Monitoring of the Antituberculosis Drug Pyrazinamide. [PDF]

Antibiotics (Basel)
Ndaro AJ, Semvua HH, Mtabho CM, Heijens CAW, Te Brake LHM, Kibiki GS, Aarnoutse RE.   +6 more
europepmc   +1 more source

Epidemiology of extrapulmonary tuberculosis, Alameda County, California, 2010-2021. [PDF]

J Clin Tuberc Other Mycobact Dis
Nasir S, Marusinec R, Chitnis AS, Jaganath D.   +3 more
europepmc   +1 more source

Open-access genomic drug resistance prediction tools for <i>Mycobacterium tuberculosis</i>: a systematic review and meta-analysis. [PDF]

J Clin Microbiol
Dewaele K, Jouego C, Asim A, Laenen L, Meehan C, André E.   +5 more
europepmc   +1 more source

Prevalence, Transmission and Genetic Diversity of Pyrazinamide Resistance Among Multidrug-Resistant Mycobacterium tuberculosis Isolates in Hunan, China

Binbin Liu,1,* Pan Su,1,* Peilei Hu,1,* Mi Yan,1 Wenbin Li,1 Songlin Yi,1 Zhenhua Chen,1 Xiaoping Zhang,1 Jingwei Guo,1 Xiaojie Wan,1 Jue Wang,1 Daofang Gong,1 Hua Bai,1 Kanglin Wan,2 Haican Liu,2 Guilian Li,2 Yunhong Tan1 1Clinical ...
Yan M, Liu H, Li G, Yi S, Wan X, Wang J, Li W, Gong D, Guo J, Su P, Chen Z, Zhang X, Tan Y, Wan K, Liu B, Bai H, Hu P   +16 more
core  

Pharmacokinetic and pharmacogenomic predictors of hepatotoxicity in the HIRIF trial for drug-susceptible tuberculosis. [PDF]

Clin Infect Dis
Yang E, Van Brantegem P, Peloquin CA, Brooks MB, Coit JM, Vargas Vásquez D, Sánchez Garavito E, Calderón RI, Jiménez J, Tintaya K, Garcia D, Osso E, Mackay EA, Platt G, Lecca L, Savic RM, Davies GR, Mitnick CD, Velásquez GE.   +18 more
europepmc   +1 more source

Concurrent Pulmonary Detection of Nocardia beijingensis, Mycobacterium tuberculosis, and Mycobacterium fortuitum in a Liver Transplant Recipient. [PDF]

J Brown Hosp Med
Membreno A, Martinez A, Bilenkin A, Saugar EE, Del Pilar Bonilla L, Porras A.   +5 more
europepmc   +1 more source

Acetylator status-guided rapid reintroduction of isoniazid in tuberculosis patients with drug-induced hepatotoxicity. [PDF]

J Clin Tuberc Other Mycobact Dis
van Arkel C, Stemkens R, Magis-Escurra C, Hoefsloot W, Carpaij N, van Ingen J, van Crevel R, van Laarhoven A, Aarnoutse R.   +8 more
europepmc   +1 more source

Utility of Patch Testing, LTT, and HLA Genotyping in Identifying Culprit Drugs and Diagnosing Multiple Drug Hypersensitivity in Definite DRESS: A 10-Year Cohort Study. [PDF]

Clin Transl Allergy
Ünal D, Yeğit OO, Demir S, Erden B, Korkmaz P, Oğuz FS, Çınar ÇK, Temurhan S, Karabacak DE, Toprak ID, Kılınç Z, Yordam MS, Kahveci N, İğde MH, Kamacı ŞÇ, Aslan AF, Sezgin ME, Kaya E, Bölek L, Coşkun R, Olgaç M, Öztop N, Gelincik A.   +22 more
europepmc   +1 more source

Anti-tuberculosis drug treatment and adverse reactions in 546 children with tuberculosis in Chongqing, China: A 10-year retrospective study. [PDF]

J Int Med Res
Wang X, Xu H.
europepmc   +1 more source